2025/09/16 更新

写真a

ハナマツ ヒサトシ
花松 久寿
HANAMATSU Hisatoshi
所属
糖鎖生命コア研究所 糖鎖ビッグデータセンター 数理解析部門 特任講師
職名
特任講師
 

論文 18

  1. Novel glycan-related biomarker discovery by total glycomic and focused protein glycomic analyses Open Access

    Hanamatsu, H; Suda, G; Ohara, M; Kurogochi, M; Sakamoto, N; Furukawa, JI

    JOURNAL OF HUMAN GENETICS     2025年8月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Human Genetics  

    The cell surface is covered with a variety of glycan subtypes (sub-glycans) such as N-glycans, O-glycans, glycosphingolipid-glycans, and glycosaminoglycans, which are collectively called the glycocalyx. The expression patterns of sub-glycans change in response to various biological events during disease pathogenesis; however, the structures of all major sub-glycans and their relative concentrations in a cell have been hardly reported. Total glycomic analysis, which comprehensively measures all major sub-glycans, is a powerful tool to discover cellular and clinical biomarkers. In this review, we provide an overview of the analytical methods for sub-glycans and the total glycome in cultured cell lines, human serum, mouse brain tissue, and human osteoarthritis cartilage. This approach not only facilitates characterization of cells, but also has applications for hierarchical clustering analysis, glycan-related biomarker discovery, and investigation of the relationship between sub-glycans and gene expression levels using the total glycome. Moreover, we discuss our recent research focused on identifying potential biomarkers of nonalcoholic fatty liver disease. These glycomic technologies are expected to contribute to diagnostics and drug development for rare diseases in the future.

    DOI: 10.1038/s10038-025-01377-3

    Open Access

    Web of Science

    Scopus

    PubMed

  2. Elevated A2F bisect <i>N</i>-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD Open Access

    Hanamatsu, H; Suda, G; Ohara, M; Ogawa, K; Tamaki, N; Hikita, H; Haga, H; Maekawa, S; Sugiyama, M; Kakisaka, T; Nakai, M; Sho, T; Miura, N; Kurosaki, M; Asahina, Y; Taketomi, A; Ueno, Y; Takehara, T; Nishikaze, T; Furukawa, JI; Sakamoto, N

    JOURNAL OF GASTROENTEROLOGY   60 巻 ( 4 ) 頁: 456 - 468   2025年4月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Gastroenterology  

    Background: Advanced liver fibrosis in cases of metabolic dysfunction-associated steatotic liver disease (MASLD) leads to cirrhosis and hepatocellular carcinoma. The current gold standard for liver fibrosis is invasive liver biopsy. Therefore, a less invasive biomarker that accurately reflects the stage of liver fibrosis is highly desirable. Methods: This study enrolled 269 patients with liver biopsy-proven MASLD. Patients were divided into three groups (F0/1 (n = 41/85), F2 (n = 47), and F3/4 (n = 72/24)) according to fibrosis stage. We performed serum N-glycomics and identified glycan biomarker for fibrosis stage. Moreover, we explored the carrier proteins and developed a sandwich ELISA to measure N-glycosylation changes of carrier protein. Results: Comprehensive N-glycomic analysis revealed significant changes in the expression of A2F bisect and its precursors as fibrosis progressed. The sum of neutral N-glycans carrying bisecting GlcNAc and core Fuc (neutral sum) had a better diagnostic performance to evaluate advanced liver fibrosis (AUC = 0.804) than conventional parameters (FIB4 index, aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), and serum level of Mac-2-binding protein glycol isomer (M2BPGi). The combination of the neutral sum and FIB4 index enhanced diagnostic performance (AUC = 0.840). IgM, IgA, and complement C3 were identified as carrier proteins with A2F bisect N-glycan. A sandwich ELISA based on N-glycans carrying bisecting GlcNAc and IgA showed similar diagnostic performance than the neutral sum. Conclusions: A2F bisect N-glycan and its precursors are promising candidate biomarkers for advanced fibrosis in MASLD patients. Analysis of these glycan alterations on IgA may have the potential to serve as a novel ELISA diagnostic tool for MASLD in routine clinical practice. Clinical trial number: UMIN000030720.

    DOI: 10.1007/s00535-024-02206-8

    Open Access

    Web of Science

    Scopus

    PubMed

  3. Total glycome analysis: glycosphingolipid-glycomics Open Access

    Hanamatsu Hisatoshi, Furukawa Jun-ichi

    Glycoforum   28 巻 ( 1 ) 頁: A1   2025年2月

     詳細を見る

    記述言語:英語   出版者・発行元:SEIKAGAKU CORPORATION  

    DOI: 10.32285/glycoforum.28a1

    Open Access

    CiNii Research

  4. 総合グライコーム解析 -スフィンゴ糖脂質糖鎖解析- Open Access

    花松 久寿, 古川 潤一

      28 巻 ( 1 ) 頁: A1J   2025年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:生化学工業株式会社  

    DOI: 10.32285/glycoforum.28a1j

    Open Access

    CiNii Research

  5. Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy Open Access

    Furukawa, S; Fukami, Y; Hanamatsu, H; Yokota, I; Furukawa, JI; Hane, M; Kitajima, K; Sato, C; Hiraga, K; Satake, Y; Yagi, S; Koike, H; Katsuno, M

    EUROPEAN JOURNAL OF NEUROLOGY   32 巻 ( 1 ) 頁: e70023   2025年1月

     詳細を見る

    記述言語:英語   出版者・発行元:European Journal of Neurology  

    Background: This study conducted a comprehensive glycan analysis of serum to determine how glycan biomarkers are associated with the pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP) and the effects of its treatment. Methods: We comparatively analyzed N- and O-glycans in the pretreatment serum of 27 treatment-naïve patients with typical CIDP and 20 age- and sex-matched healthy controls (HC) using mass spectrometry. We determined the association between clinical parameters and glycans. The serum glycan and neurofilament light-chain (NfL) levels were assessed at the baseline, and treatment response was defined according to the degree of improvement in the modified Rankin scale 12 weeks after the first dose of intravenous immunoglobulin (IVIg). Results: Compared with the HC, the CIDP group demonstrated significantly lower levels of serum total N-glycans (CIDP, median 973.3 [IQR 836.2–1131.3] pmol/μL; HC, 1125.0 [1005.0–1236.2] pmol/μL; p < 0.05), especially sialylated N-glycans (CIDP, 898.0 [752.2–1037.2] pmol/μL; HC, 1064.4 [942.7–1189.8] pmol/μL; p < 0.01). In contrast, the O-glycan levels did not differ significantly between the two groups. The treatment response was associated with low N-glycan levels, but not with the serum NfL levels. Low levels of sialylated N-glycans were associated with resistance to treatment over 12 weeks, with an area under the curve of 0.822 (p < 0.01). Conclusions: Low levels of sialylated N-glycans could potentially serve as a novel biomarker, reflecting pathophysiology and therapeutic resistance in typical CIDP.

    DOI: 10.1111/ene.70023

    Web of Science

    Scopus

    PubMed

  6. Advances in total glycomic analysis including sialylated sub-glycan isomers by SALSA method Open Access

    Kurogochi, M; Suzuki, C; Hanamatsu, H; Furukawa, JI

    BBA ADVANCES   7 巻   頁: 100144   2025年

     詳細を見る

    記述言語:英語   出版者・発行元:Bba Advances  

    All eukaryotic cell surfaces are coated with various types of glycans, which are essential molecules in biological events. In this review, we summarize recent integrated glycomics studies using various biological samples. We introduce an improved sialic acid linkage-specific alkylamidation (SALSA) method for sialylated glycan analysis and an automated glycosphingolipid-glycan preparation system for large-scale glycomic analysis of human plasma/serum. Finally, we explain the importance of integrated glycomics of glycoconjugates through total glycomic analysis of human serum and mouse brain tissue, and discuss prospects for exploring glycans as effective biomarkers of biological phenomena.

    DOI: 10.1016/j.bbadva.2025.100144

    Open Access

    Web of Science

    Scopus

    PubMed

  7. Edible bird's nest: <i>N</i>- and <i>O</i>-glycan analysis and synergistic anti-avian influenza virus activity with neuraminidase inhibitors

    Sriwilaijaroen, N; Hanamatsu, H; Yokota, I; Nishikaze, T; Ijichi, T; Takahashi, T; Sakoda, Y; Furukawa, J; Suzuki, Y

    ANTIVIRAL RESEARCH   232 巻   頁: 106040   2024年12月

     詳細を見る

    記述言語:英語   出版者・発行元:Antiviral Research  

    Zoonotic avian influenza viruses have continued to infect people on occasion. During treatment, antiviral resistant viruses have occasionally emerged, highlighting the need for a novel strategy for treating human illness. After pancreatin treatment, edible bird's nest (EBN), swiftlet saliva consumed for health purposes, possesses anti-avian viral activity by inhibiting receptor-binding hemagglutinin (HA) activity. Glycan analysis revealed an abundance of α2,3Neu5Ac decoy receptors in pancreatin-treated EBN. Fucosylated tri-α2,3Neu5Ac tri-antennary N-glycans (N-35) and di-α2,3Neu5Ac core 2 O-glycans (O-15) are predominant, accounting for 53.46% and 44.66% of total N- and O-glycan amounts, respectively. Isobologram analysis revealed that the treated EBN had a strong synergistic effect with either oseltamivir carboxylate or zanamivir, a competitive inhibitor of receptor-destroying neuraminidases (NAs), against the avian H5N1 virus. Taken together, EBN has the potential to be developed as a food-derived avian viral trap to prevent and decrease avian virus infection as well as in combination with a viral releasing-NA inhibitor to increase therapeutic potency, reduce toxicity, delay resistance development, and potentially prevent pandemic onset.

    DOI: 10.1016/j.antiviral.2024.106040

    Web of Science

    Scopus

    PubMed

  8. Associations between glycan signature alterations and the cellular antigenic properties of passaged chondrocytes Open Access

    Homan, K; Tokuhiro, T; Onodera, T; Hanamatsu, H; Furukawa, JI; Ebata, T; Matsuoka, M; Kadoya, K; Terkawi, MA; Iwasaki, N

    FRONTIERS IN IMMUNOLOGY   15 巻   頁: 1475473   2024年11月

     詳細を見る

    記述言語:英語   出版者・発行元:Frontiers in Immunology  

    Background: Cartilage repair is a significant clinical challenge because of the limited intrinsic healing capacity. Current therapeutic strategies, such as cell transplantation therapy, aim to overcome this challenge by replacing damaged tissue with healthy cells. However, the long-term survival and functionality of transplanted cells remain major hurdles. Objective: This study investigated the impact of chondrocyte passaging on glycan profiles and their antigenic properties. We hypothesized that alterations in glycan composition due to passaging may contribute to the enhanced ability to activate macrophages, thereby affecting the outcome of cell transplantation therapy. Methods: Peritoneal macrophages and primary articular chondrocytes were isolated from C57BL/6 mice to establish direct and indirect coculture models. Macrophage activation was assessed by measuring the concentrations of IL-6 and nitric oxide in the culture supernatants or their gene expression. Glycome analysis of various glycoconjugates was performed by glycoblotting methods combined with the SALSA procedure for N-glycans and GSLs and the BEP method for O-glycans. Results: Our results revealed that direct coculture of macrophages with passaged chondrocytes increased the production of proinflammatory cytokines, including IL-6 and NO, as the number of passages increased. With increasing passage number, the expression of GD3 substantially decreased, and the expression of GM3, especially GD1a, significantly increased. Coculturing passaged GM3S knockout chondrocytes with macrophages significantly suppressed IL-6 expression, implying reduced macrophage activation. Conclusion: The observed activation of macrophages due to alterations in the glycan profile of chondrocytes provides a possible explanation for the antigenicity and immune rejection of transplanted cells.

    DOI: 10.3389/fimmu.2024.1475473

    Open Access

    Web of Science

    Scopus

    PubMed

  9. Direct derivatization of sialic acids and mild β-elimination for linkage-specific sialyl<i> O</i>-glycan analysis Open Access

    Hanamatsu, H; Yokota, I; Kurogochi, M; Akasaka-Manya, K; Miura, N; Manya, H; Endo, T; Nishikaze, T; Furukawa, J; Tanaka, K

    ANALYTICA CHIMICA ACTA   1318 巻   頁: 342945   2024年8月

     詳細を見る

    記述言語:英語   出版者・発行元:Analytica Chimica Acta  

    Background: In sharp contrast with analysis of N-glycan that can be prepared by PNGase F, O-glycan analysis remains challenging due to a lack of versatile and simple procedures, especially those mediating cleavage of O-glycans from proteins. Most N-glycans and O-glycans are modified with sialic acids at the non-reducing end and their glycosidic linkages are labile, making it difficult to measure glycans by mass spectrometric analysis. In addition, sialic acid residues present on glycan chains via α2,3-, α2,6-, and α2,8-linkages as structural isomers. Results: In this study, we firstly established a direct and linkage-specific derivatization method for sialylated O-glycans on proteins via linkage-specific lactone-opening aminolysis. In this procedure, labile sialylated glycans were not only stabilized, but also allowed distinguishing between sialyl linkages. Furthermore, we revealed that general reductive β-elimination was not useful for O-glycan cleavages with undesirable degradations of resulting methyl amides. Using β-elimination in the presence of pyrazolone (PMP), with low pH despite alkali base concentration, SALSA-derivatized O-glycans could be cleaved with minimal degradations. Cleaved and PMP-labeled O-glycans could be efficiently prepared in an open reaction system at high temperature (evaporative BEP reaction) and detected by simple liquid-phase extraction. Moreover, in the evaporative BEP reaction by changing the alkali solution with LiOH, the lithiated O-glycans could be observed and provided a lot of fragment information reflecting the complex structure of the O-glycans. Significance: Direct sialic acid linkage-specific derivatization of O-glycans on glycoproteins is simple protocol containing in-solution aminolysis-SALSA and acetonitrile precipitation for removal of excess reagents. Evaporative β-elimination with pyrazolone makes possible intact O-linked glycan analysis just by liquid-phase extraction. These analytical methods established by the appropriate combination of direct-SALSA and evaporative β-elimination will facilitate O-glycomic studies in various biological samples.

    DOI: 10.1016/j.aca.2024.342945

    Open Access

    Web of Science

    Scopus

    PubMed

  10. SERUM GLYCOBIOMARKERS DEFINING THERAPEUTIC RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

    Furukawa, S; Fukami, Y; Yokota, I; Hanamatsu, H; Furukawa, JI; Hane, M; Kitajima, K; Sato, C; Hiraga, K; Satake, Y; Yagi, S; Koike, H; Katsuno, M

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM   29 巻   頁: S92 - S92   2024年8月

     詳細を見る

  11. 総合グライコーム解析 −N-結合型糖鎖解析−

    花松 久寿, 黒河内 政樹, 古川 潤一

      27 巻 ( 3 ) 頁: A9J   2024年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:生化学工業株式会社  

    DOI: 10.32285/glycoforum.27a9j

    CiNii Research

  12. Total glycome analysis —N-glycomics—

    Hanamatsu Hisatoshi, Kurogochi Masaki, Furukawa Jun-ichi

    Glycoforum   27 巻 ( 3 ) 頁: A9   2024年6月

     詳細を見る

    記述言語:英語   出版者・発行元:SEIKAGAKU CORPORATION  

    DOI: 10.32285/glycoforum.27a9

    CiNii Research

  13. Articular cartilage corefucosylation regulates tissue resilience in osteoarthritis Open Access

    Homan, K; Onodera, T; Hanamatsu, H; Furukawa, J; Momma, D; Matsuoka, M; Iwasaki, N

    ELIFE   12 巻   2024年3月

     詳細を見る

    記述言語:英語   出版者・発行元:eLife  

    This study aimed to investigate the glycan structural changes that occur before histological degeneration in osteoarthritis (OA) and to determine the mechanism by which these glycan conformational changes affect cartilage degeneration. An OA model was established in rabbits using mannosidase injection, which reduced high-mannose type N-glycans and led to cartilage degeneration. Further analysis of glycome in human OA cartilage identified specific corefucosylated N-glycan expression patterns. Inhibition of N-glycan corefucosylation in mice resulted in unrecoverable cartilage degeneration, while cartilage-specific blocking of corefucosylation led to accelerated development of aging-associated and instability-induced OA models. We conclude that α1,6 fucosyltransferase is required postnatally to prevent preosteoarthritic deterioration of articular cartilage. These findings provide a novel definition of early OA and identify glyco-phenotypes of OA cartilage, which may distinguish individuals at higher risk of progression.

    DOI: 10.7554/eLife.92275

    Open Access

    Web of Science

    Scopus

    PubMed

  14. Tolerable glycometabolic stress boosts cancer cell resilience through altered <i>N</i>-glycosylation and Notch signaling activation Open Access

    Iwamoto, S; Kobayashi, T; Hanamatsu, H; Yokota, I; Teranishi, Y; Iwamoto, A; Kitagawa, M; Ashida, S; Sakurai, A; Matsuo, S; Myokan, Y; Sugimoto, A; Ushioda, R; Nagata, K; Gotoh, N; Nakajima, K; Nishikaze, T; Furukawa, J; Itano, N

    CELL DEATH & DISEASE   15 巻 ( 1 ) 頁: 53   2024年1月

     詳細を見る

    記述言語:英語   出版者・発行元:Cell Death and Disease  

    Chronic metabolic stress paradoxically elicits pro-tumorigenic signals that facilitate cancer stem cell (CSC) development. Therefore, elucidating the metabolic sensing and signaling mechanisms governing cancer cell stemness can provide insights into ameliorating cancer relapse and therapeutic resistance. Here, we provide convincing evidence that chronic metabolic stress triggered by hyaluronan production augments CSC-like traits and chemoresistance by partially impairing nucleotide sugar metabolism, dolichol lipid-linked oligosaccharide (LLO) biosynthesis and N-glycan assembly. Notably, preconditioning with either low-dose tunicamycin or 2-deoxy-D-glucose, which partially interferes with LLO biosynthesis, reproduced the promoting effects of hyaluronan production on CSCs. Multi-omics revealed characteristic changes in N-glycan profiles and Notch signaling activation in cancer cells exposed to mild glycometabolic stress. Restoration of N-glycan assembly with glucosamine and mannose supplementation and Notch signaling blockade attenuated CSC-like properties and further enhanced the therapeutic efficacy of cisplatin. Therefore, our findings uncover a novel mechanism by which tolerable glycometabolic stress boosts cancer cell resilience through altered N-glycosylation and Notch signaling activation.

    DOI: 10.1038/s41419-024-06432-z

    Open Access

    Web of Science

    Scopus

    PubMed

  15. Novel Sialic Acid Linkage-Specific <i>O</i>-Linked Glycan Analysis Method via Ester-to-Amide Derivatization

    Hanamatsu, H; Yokota, I; Miura, N; Furukawa, J

    GLYCOBIOLOGY   33 巻 ( 11 ) 頁: 1060 - 1061   2023年12月

     詳細を見る

  16. Exposure to brefeldin A induces unusual expression of hybrid- and complex-type free N-glycans in HepG2 cells Open Access

    Sugiura, K; Kawai, Y; Yamamoto, A; Yoshioka, H; Kiyohara, Y; Iida, A; Ozawa, Y; Nishikawa, M; Miura, N; Hanamatsu, H; Furukawa, JI; Shinohara, Y

    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS   1867 巻 ( 5 ) 頁: 130331   2023年5月

     詳細を見る

    記述言語:英語   出版者・発行元:Biochimica et Biophysica Acta - General Subjects  

    This study determined the effect of brefeldin A (BFA) on the free N-glycomic profile of HepG2 cells to better understand the effect of blocking intracellular vesicle formation and transport of proteins from the endoplasmic reticulum to the Golgi apparatus. A series of exoglycosidase- and endoglycosidase-assisted analyses clarified the complex nature of altered glycomic profiles. A key feature of BFA-mediated alterations in Gn2-type glycans was the expression of unusual hybrid-, monoantennary- and complex-type free N-glycans (FNGs). BFA-mediated alterations in Gn1-type glycans were characterized by the expression of unusual hybrid- and monoantennary-FNGs, without significant expression of complex-type FNGs. A time course analysis revealed that sialylated hybrid- and complex-type Gn2-type FNGs were generated later than asialo-Gn2-type FNGs, and the expression profiles of Gn2-type FNGs and N-glycans were found to be similar, suggesting that the metabolic flux of FNGs is the same as that of protein-bound N-glycans. Subcellular glycomic analysis revealed that almost all FNGs were detected in the cytoplasmic extracts. Our data suggest that hybrid-, monoantennary- and complex-type Gn2-type FNGs were cleaved from glycoproteins in the cytosol by cytosolic PNGase, and subsequently digested by cytosolic endo-β-N-acetylglucosaminidase (ENGase) to generate Gn1-type FNGs. The substrate specificity of ENGase explains the limited expression of complex Gn1 type FNGs.

    DOI: 10.1016/j.bbagen.2023.130331

    Web of Science

    Scopus

    PubMed

  17. Simultaneous and sialic acid linkage-specific N- and O-linked glycan analysis by ester-to-amide derivatization

    Hanamatsu, H; Miura, Y; Nishikaze, T; Yokota, I; Homan, K; Onodera, T; Hayakawa, Y; Iwasaki, N; Furukawa, JI

    GLYCOCONJUGATE JOURNAL   40 巻 ( 2 ) 頁: 259 - 267   2023年4月

     詳細を見る

    記述言語:英語   出版者・発行元:Glycoconjugate Journal  

    Characterization of O-glycans linked to serine or threonine residues in glycoproteins has mostly been achieved using chemical reaction approaches because there are no known O-glycan-specific endoglycosidases. Most O-glycans are modified with sialic acid residues at the non-reducing termini through various linkages. In this study, we developed a novel approach for sialic acid linkage-specific O-linked glycan analysis through lactone-driven ester-to-amide derivatization combined with non-reductive β-elimination in the presence of hydroxylamine. O-glycans released by non-reductive β-elimination were efficiently purified using glycoblotting via chemoselective ligation between carbohydrates and a hydrazide-functionalized polymer, followed by modification of methyl or ethyl ester groups of sialic acid residues on solid-phase. In-solution lactone-driven ester-to-amide derivatization of ethyl-esterified O-glycans was performed, and the resulting sialylated glycan isomers were discriminated by mass spectrometry. In combination with PNGase F digestion, we carried out simultaneous, quantitative, and sialic acid linkage-specific N- and O-linked glycan analyses of a model glycoprotein and human cartilage tissue. This novel glycomic approach will facilitate detailed characterization of biologically relevant sialylated N- and O-glycans on glycoproteins.

    DOI: 10.1007/s10719-023-10109-8

    Web of Science

    Scopus

    PubMed

  18. Simultaneous determination of heparan sulfate, chondroitin/dermatan sulfates, and hyaluronan glycosaminoglycan disaccharides by high-performance liquid chromatography using a reverse-phase column with adamantyl groups

    Hanamatsu, H; Makino, S; Ohara, M; Suda, G; Yokota, I; Nishihara, S; Sakamoto, N; Furukawa, J

    JOURNAL OF CHROMATOGRAPHY A   1689 巻   頁: 463748   2023年1月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Chromatography A  

    Glycosaminoglycans (GAGs), which are one of the major components of proteoglycans, play a pivotal role in physiological processes such as signal transduction, cell adhesion, growth, and differentiation. Characterization of GAGs is challenging due to the tremendous structural diversity of heteropolysaccharides with numerous sulfate or carboxyl groups. In this present study, we examined the analysis of 2-aminobenzamide (2-AB) labeled GAG disaccharides by high-performance liquid chromatography (HPLC) using a reverse-phase (RP)-column with adamantyl groups. Under the analytical conditions, 17 types of 2-AB labeled GAG disaccharides derived from heparan sulfate, chondroitin/dermatan sulfates, and hyaluronan were sequentially separated in a single analysis. The analysis time was fast with high retention time reproducibility. Moreover, the RP-HPLC column with adamantyl groups allowed the quantification of GAGs in various biological samples, such as serum, cultured cells, and culture medium.

    DOI: 10.1016/j.chroma.2022.463748

    Web of Science

    Scopus

    PubMed

▼全件表示

書籍等出版物 1

  1. Comprehensive Glycan Analysis of Sphingolipids in Human Serum/Plasma

    Hanamatsu H., Nishikaze T., Furukawa J.i.

    Methods in Molecular Biology  2023年 

     詳細を見る

    記述言語:英語

    Glycosphingolipids (GSLs) are glycolipids with ceramide and carbohydrate head groups that play an important role in numerous biological processes. Previously, we performed GSL-glycan analysis of various cell lines and virus-infected cells using a glycoblotting approach. Recently, we developed several methods for sialic acid linkage-specific chemical modification to distinguish sialylated glycan isomers by mass spectrometry. In this chapter, we describe a method for analyzing GSL-glycans in human serum/plasma using glycoblotting combined with aminolysis-SALSA (sialic acid linkage-specific alkylamidation) and lactone-driven ester-to-amide derivatization (LEAD)-SALSA for comprehensive and detailed structural glycomics.

    DOI: 10.1007/978-1-0716-2910-9_21

    Scopus

    PubMed

科研費 2

  1. O型糖鎖の新規シアル酸構造異性体識別法および切断法の開発とその応用

    研究課題/研究課題番号:24K08478  2024年4月 - 2027年3月

    科学研究費助成事業  基盤研究(C)

    花松 久寿

      詳細を見る

    担当区分:研究代表者 

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

  2. 機能性糖脂質分子を導入した新規軟骨再生材料の開発

    研究課題/研究課題番号:22H03917  2022年4月 - 2025年3月

    科学研究費助成事業  基盤研究(B)

    小野寺 智洋, 長濱 宏治, 照川 アラー, 花松 久寿, 松岡 正剛

      詳細を見る

    担当区分:研究分担者 

    変形性関節症は労働人口に対して関節痛を起因とした運動機能低下を引き起こすことが社会的に大きな問題となるが、その病態は明らかにされていない。これまで申請者らはガングリオシド欠損が変形性関節症を増悪させ、その発症に重要な役割を担うことを明らかにしてきた。しかし、その作用機序に関しては未だ不明な点が多い。そこで申請者らは、糖脂質糖鎖の中には変形性関節症に深く関わる分子が存在し、新たな治療ターゲットとなり得るという仮説を立てた。本研究の目的は、変形性関節症と強い関連を持つ生理活性分子を網羅的手法により特定し、バイオマテリアルに組み込むことによって、変形性関節症に対する新たな治療法を確立することである。